Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L O Pedersen

Showing results (1-10 of 23) with videos related to

Pageof 3
Sort By:
Hybridoma|February 1, 1989
An approach for characterization and purification of a human monoclonal hybridoma antibodyL O Pedersen, R B Andreasen
Virus Research|August 10, 2000
Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furinG Bolt, L O Pedersen, H H Birkeslund
European Journal of Immunology|November 28, 2000
Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanismA Stryhn, L O Pedersen, A Holm, et al.
Analytical Biochemistry|August 25, 2001
High-throughput polymerase chain reaction cleanup in microtiter formatN J Hansen, L O Pedersen, A Stryhn, et al.
European Journal of Immunology|June 1, 1994
Preformed purified peptide/major histocompatibility class I complexes are potent stimulators of class I-restricted T cell hybridomasA Stryhn, L O Pedersen, V Ortiz-Navarrete, et al.
The Journal of Experimental Medicine|July 1, 1996
T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptidesS L Larsen, L O Pedersen, S Buus, et al.
Biochimica Et Biophysica Acta|April 13, 1995
Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation methodS Buus, A Stryhn, K Winther, et al.
Cancer Research|February 28, 2001
Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patientsM H Andersen, L O Pedersen, J C Becker, et al.
International Journal of Cancer|August 24, 2001
Specific killing of P53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted P53-specific CTL lineP A Würtzen, L O Pedersen, H S Poulsen, et al.
Scandinavian Journal of Immunology|December 1, 1996
MHC class I phenotype and function of human beta 2-microglobulin transgenic murine lymphocytesL Bjerager, L O Pedersen, S Bregenholt, et al.
Pageof 3

Showing results (1-10 of 23) with videos related to

Sort By:
Pageof 3
Hybridoma|February 1, 1989
An approach for characterization and purification of a human monoclonal hybridoma antibodyL O Pedersen, R B Andreasen
Virus Research|August 10, 2000
Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furinG Bolt, L O Pedersen, H H Birkeslund
European Journal of Immunology|November 28, 2000
Longer peptide can be accommodated in the MHC class I binding site by a protrusion mechanismA Stryhn, L O Pedersen, A Holm, et al.
Analytical Biochemistry|August 25, 2001
High-throughput polymerase chain reaction cleanup in microtiter formatN J Hansen, L O Pedersen, A Stryhn, et al.
European Journal of Immunology|June 1, 1994
Preformed purified peptide/major histocompatibility class I complexes are potent stimulators of class I-restricted T cell hybridomasA Stryhn, L O Pedersen, V Ortiz-Navarrete, et al.
The Journal of Experimental Medicine|July 1, 1996
T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class II-bound peptidesS L Larsen, L O Pedersen, S Buus, et al.
Biochimica Et Biophysica Acta|April 13, 1995
Receptor-ligand interactions measured by an improved spun column chromatography technique. A high efficiency and high throughput size separation methodS Buus, A Stryhn, K Winther, et al.
Cancer Research|February 28, 2001
Identification of a cytotoxic T lymphocyte response to the apoptosis inhibitor protein survivin in cancer patientsM H Andersen, L O Pedersen, J C Becker, et al.
International Journal of Cancer|August 24, 2001
Specific killing of P53 mutated tumor cell lines by a cross-reactive human HLA-A2-restricted P53-specific CTL lineP A Würtzen, L O Pedersen, H S Poulsen, et al.
Scandinavian Journal of Immunology|December 1, 1996
MHC class I phenotype and function of human beta 2-microglobulin transgenic murine lymphocytesL Bjerager, L O Pedersen, S Bregenholt, et al.
Pageof 3